<code id='95E8B1F757'></code><style id='95E8B1F757'></style>
    • <acronym id='95E8B1F757'></acronym>
      <center id='95E8B1F757'><center id='95E8B1F757'><tfoot id='95E8B1F757'></tfoot></center><abbr id='95E8B1F757'><dir id='95E8B1F757'><tfoot id='95E8B1F757'></tfoot><noframes id='95E8B1F757'>

    • <optgroup id='95E8B1F757'><strike id='95E8B1F757'><sup id='95E8B1F757'></sup></strike><code id='95E8B1F757'></code></optgroup>
        1. <b id='95E8B1F757'><label id='95E8B1F757'><select id='95E8B1F757'><dt id='95E8B1F757'><span id='95E8B1F757'></span></dt></select></label></b><u id='95E8B1F757'></u>
          <i id='95E8B1F757'><strike id='95E8B1F757'><tt id='95E8B1F757'><pre id='95E8B1F757'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:434
          Lauren Gavron walking with prosthetic in a lab at the University of Pittsburgh. Courtesy Nathan Langer/UPMC & Pitt Health Sciences

          For years, Lauren Gavron relied on oxycodone to quiet the pain in her missing lower left limb. But she hated the fog that came with it, preventing her from feeling comfortable enough to drive.

          When researchers at the University of Pittsburgh delivered electric jolts to her spine in 2021, the Duquesne, Pennsylvania resident was shocked to feel that pain temporarily melt away — and to feel sensation in her prosthetic foot, improving her walk and balance.

          advertisement

          “You really wouldn’t believe it,” Gavron, 67, said. “As soon as the pain would start, it just all went away.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study
          Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

          AdobeAcadiaPharmaceuticalssaidMondaythatitsapprovedmedicinecalledNuplazidfailedtoimprovethesocialand

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          How to make over

          AdobeTheFoodandDrugAdministrationrecentlyapprovedOpill,thefirstover-the-counteraccessbirthcontrolpil